Literature DB >> 25964099

Oligodendroglial maldevelopment in the cerebellum after postnatal hyperoxia and its prevention by minocycline.

Till Scheuer1,2, Vivien Brockmöller1, Marissa Blanco Knowlton3, Jörn-Hendrik Weitkamp3, Torben Ruhwedel4, Susanne Mueller5, Stefanie Endesfelder1, Christoph Bührer1, Thomas Schmitz1.   

Abstract

According to recent research, brain injury after premature birth often includes impaired growth of the cerebellum. However, causes of cerebellar injury in this population are poorly understood. In this study, we analyzed whether postnatal hyperoxia perturbs white matter development of the cerebellum, and whether cerebellar glial damage can be prevented by minocycline. We used a hyperoxia model in neonatal rats providing 24 h exposure to fourfold increased oxygen concentration (80% O2) from P6 to P7, followed by recovery in room air until P9, P11, P15, P30. Injections with minocycline were performed at the beginning and 12 h into hyperoxia exposure. Hyperoxia induced oxidative stress in the cerebellum at P7 as evidenced by increased nitrotyrosine concentrations. Numbers of proliferating, NG2+Ki67+ oligodendroglial precursor cells were decreased at P7 after hyperoxia and at P11 following recovery in room air. Numbers of mature, CC1+ oligodendrocytes were diminished in recovering hyperoxia rats, and myelin basic protein expression was still decreased at P30. Electron microscopy analysis of myelinated fibers at P30 revealed thinner myelin sheath after hyperoxia. Long-term injury of the cerebellum by neonatal hyperoxia was confirmed by reduced volumes in MRI measurements at P30. In response to 80% O2, expression of platelet-derived growth factor (PDGF)-A was largely reduced in cerebellar tissue and also in cultured cerebellar astrocytes. Treatment with minocycline during hyperoxia prevented oxidative stress, attenuated oligodendroglial injury, and improved astroglial PDGF-A levels. In conclusion, early hyperoxia causes white matter damage in the cerebellum with astroglial dysfunction being involved, and both can be prevented by treatment with minocycline. Neonatal exposure to hyperoxia causes hypomyelination of the cerebellum. Reduced astroglial growth factor production but not microglial inflammation seems to contribute to oligodendroglial damage, and minocycline rescues oligodendroglia development in the cerebellum after hyperoxia.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cerebellum; hyperoxia; minocycline; oligodendroglia; preterm infants; white matter damage

Mesh:

Substances:

Year:  2015        PMID: 25964099      PMCID: PMC4534324          DOI: 10.1002/glia.22847

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  78 in total

Review 1.  Physiology of microglia.

Authors:  Helmut Kettenmann; Uwe-Karsten Hanisch; Mami Noda; Alexei Verkhratsky
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

2.  A role for platelet-derived growth factor in normal gliogenesis in the central nervous system.

Authors:  W D Richardson; N Pringle; M J Mosley; B Westermark; M Dubois-Dalcq
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

3.  Developmental and growth factor-induced regulation of nestin in oligodendrocyte lineage cells.

Authors:  V Gallo; R C Armstrong
Journal:  J Neurosci       Date:  1995-01       Impact factor: 6.167

4.  Early blood gas abnormalities and the preterm brain.

Authors:  Alan Leviton; Elizabeth Allred; Karl C K Kuban; Olaf Dammann; T Michael O'Shea; Deborah Hirtz; Michael D Schreiber; Nigel Paneth
Journal:  Am J Epidemiol       Date:  2010-08-31       Impact factor: 4.897

5.  Late gestation cerebellar growth is rapid and impeded by premature birth.

Authors:  Catherine Limperopoulos; Janet S Soul; Kimberlee Gauvreau; Petra S Huppi; Simon K Warfield; Haim Bassan; Richard L Robertson; Joseph J Volpe; Adré J du Plessis
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

6.  Human oligodendrocyte precursor cells in vitro: phenotypic analysis and differential response to growth factors.

Authors:  Heather C Wilson; Claus Onischke; Cedric S Raine
Journal:  Glia       Date:  2003-11       Impact factor: 7.452

7.  Minocycline protects the immature white matter against hyperoxia.

Authors:  Thomas Schmitz; Grietje Krabbe; Georg Weikert; Till Scheuer; Friederike Matheus; Yan Wang; Susanne Mueller; Helmut Kettenmann; Vitali Matyash; Christoph Bührer; Stefanie Endesfelder
Journal:  Exp Neurol       Date:  2014-01-31       Impact factor: 5.330

8.  Estradiol attenuates hyperoxia-induced cell death in the developing white matter.

Authors:  Bettina Gerstner; Marco Sifringer; Mark Dzietko; Alexandra Schüller; Joan Lee; Sinno Simons; Michael Obladen; Joseph J Volpe; Paul A Rosenberg; Ursula Felderhoff-Mueser
Journal:  Ann Neurol       Date:  2007-06       Impact factor: 10.422

Review 9.  Cerebellum of the premature infant: rapidly developing, vulnerable, clinically important.

Authors:  Joseph J Volpe
Journal:  J Child Neurol       Date:  2009-09       Impact factor: 1.987

10.  Expression of GABA(B) receptors is altered in brains of subjects with autism.

Authors:  S Hossein Fatemi; Timothy D Folsom; Teri J Reutiman; Paul D Thuras
Journal:  Cerebellum       Date:  2009-03       Impact factor: 3.847

View more
  13 in total

Review 1.  Mitochondrial dysfunction in alveolar and white matter developmental failure in premature infants.

Authors:  Vadim S Ten
Journal:  Pediatr Res       Date:  2016-11-03       Impact factor: 3.756

2.  Neonatal Hyperoxia Perturbs Neuronal Development in the Cerebellum.

Authors:  Till Scheuer; Yuliya Sharkovska; Victor Tarabykin; Katharina Marggraf; Vivien Brockmöller; Christoph Bührer; Stefanie Endesfelder; Thomas Schmitz
Journal:  Mol Neurobiol       Date:  2017-05-25       Impact factor: 5.590

Review 3.  Neuroinflammation in preterm babies and autism spectrum disorders.

Authors:  Cindy Bokobza; Juliette Van Steenwinckel; Shyamala Mani; Valérie Mezger; Bobbi Fleiss; Pierre Gressens
Journal:  Pediatr Res       Date:  2018-11-16       Impact factor: 3.756

Review 4.  The impact of trophic and immunomodulatory factors on oligodendrocyte maturation: Potential treatments for encephalopathy of prematurity.

Authors:  Josine E G Vaes; Myrna J V Brandt; Nikki Wanders; Manon J N L Benders; Caroline G M de Theije; Pierre Gressens; Cora H Nijboer
Journal:  Glia       Date:  2020-11-30       Impact factor: 7.452

5.  Corrigendum: Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia.

Authors:  Candice E Crocker; Philip G Tibbo
Journal:  Front Pharmacol       Date:  2018-12-04       Impact factor: 5.810

Review 6.  Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia.

Authors:  Candice E Crocker; Philip G Tibbo
Journal:  Front Pharmacol       Date:  2018-10-18       Impact factor: 5.810

7.  In vitro P38MAPK inhibition in aged astrocytes decreases reactive astrocytes, inflammation and increases nutritive capacity after oxygen-glucose deprivation.

Authors:  Miren Revuelta; Amaia Elicegui; Till Scheuer; Stefanie Endesfelder; Christoph Bührer; Leire Moreno-Cugnon; Ander Matheu; Thomas Schmitz
Journal:  Aging (Albany NY)       Date:  2021-02-09       Impact factor: 5.682

8.  Supraphysiological Levels of Oxygen Exposure During the Neonatal Period Impairs Signaling Pathways Required for Learning and Memory.

Authors:  Manimaran Ramani; Ranjit Kumar; Brian Halloran; Charitharth Vivek Lal; Namasivayam Ambalavanan; Lori L McMahon
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

9.  Early Life Supraphysiological Levels of Oxygen Exposure Permanently Impairs Hippocampal Mitochondrial Function.

Authors:  Manimaran Ramani; Kiara Miller; Jamelle Brown; Ranjit Kumar; Jegen Kadasamy; Lori McMahon; Scott Ballinger; Namasivayam Ambalavanan
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

Review 10.  Glial Factors Regulating White Matter Development and Pathologies of the Cerebellum.

Authors:  Miren Revuelta; Till Scheuer; Li-Jin Chew; Thomas Schmitz
Journal:  Neurochem Res       Date:  2020-01-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.